Trends of High-Impact Studies in Pharmacology and Pharmacy: A Cross-Sectional Study.
Trends of High-Impact Studies in Pharmacology and Pharmacy: A Cross-Sectional Study.
复制标题
DOI：
10.3389/fphar.2021.726668
复制
发表时间：
2021
影响因子：
5.6
通讯作者：
Li N
中科院分区：
文献类型：
--
作者：
Chen L;Yang Y;Fan J;Zhang Y;Li N
目的：了解药理学和药学领域高影响研究的发展趋势，为今后药理学和药学领域的研究提供依据。方法：采用基于Web of Science Core Collection的InCites工具进行横断面研究，了解药理学和药学研究中高影响力研究（前1%）的现状。使用VOSViewer软件将结果可视化。结果包括发展趋势、国家、学科领域、研究机构、合作网络和学科术语。结果：2011年至2020年间，我们在药理学和药学领域发现了4273篇高影响力（前1%）的研究。研究数量从2011年的366项增加到2020年的510项。这些研究主要分布在以下Web of Science学科类别中：药理学和药学（n = 4188）；神经科学（n = 397）；化学，多学科（n = 359）；化学，医药（n = 314）；微生物学（301例）；生物技术和应用微生物学（n = 280）。这些研究在100多个Web of Science学科类别的646,855项研究中被引用，其中药理学药学研究占这些引用的最大份额。贡献研究数量最多的前三个国家是美国、英国和中国。在美国，贡献研究数量最多的前三所大学是加州大学系统、美国国立卫生研究院（NIH）和哈佛大学。顶尖的科研合作圈来自美国的大学。国际合作圈排名靠前的是美国、英国、澳大利亚和中国的大学。研究结果显示，肿瘤仍是首选疾病，NF-κB仍是首选信号通路，给药和纳米颗粒仍是首选方法。结论：随着时间的推移，药理学和药学研究的高影响力研究越来越多。美国、英国和中国是贡献高影响力研究的主要国家。癌症仍然是疾病治疗领域最大的挑战。它呼吁在药理学和药学研究方面进行更多的国际合作，这将有助于发现新药。
Objective: To investigate the trends of high-impact studies in pharmacology and pharmacy research and to provide evidence for future research in the field of pharmacology and pharmacy. Methods: A cross-sectional study was performed to understand the current status of high-impact studies (top 1%) in pharmacology and pharmacy research via InCites tool based on Web of Science Core Collection. VOSViewer software was used to visualize the results. The outcomes included development trends, countries, subject areas, research institutes, collaborative networks, and subject terms. Results: We found 4,273 high-impact (top 1%) studies between 2011 and 2020 in the field of pharmacology and pharmacy. The number of studies increased from 366 in 2011 to 510 in 2020. These studies were mainly distributed in the following Web of Science subject categories: pharmacology and pharmacy (n = 4,188); neurosciences (n = 397); chemistry, multidisciplinary (n = 359); chemistry, medicinal (n = 314); microbiology (n = 301); biotechnology and applied microbiology (n = 280). These studies were cited in 646,855 studies from more than 100 Web of Science subject categories, and studies in pharmacology pharmacy accounted for the largest share of these citations. The top three countries that contributed the highest number of studies were the United States, United Kingdom, and China. The top three institutions that contributed the highest number of studies in the United States were the University of California System, the National Institutes of Health (NIH), and Harvard University. The top research collaborative circle was from universities in the United States. The top international collaborative circle was from universities from the United States, United Kingdom, Australia, and China. The subject-term analysis indicated that cancer was still the top disease, NF-κB was the top signaling pathway, and drug-delivery and nanoparticles were the top methods. Conclusion: The high-impact studies in pharmacology and pharmacy research have grown over time. The United States, the United Kingdom, and China are the top countries that contributed the high-impact studies. Cancer is still the greatest challenge in the field of disease treatment. It calls for more international collaboration in pharmacology and pharmacy research, which will help discover novel drugs.
登录
查看更多内容
影响因子：
7.4
作者：
Reuter, Simone;Gupta, Subash C.;Chaturvedi, Madan M.;Aggarwal, Bharat B.
通讯作者：
Aggarwal, Bharat B.
影响因子：
2.7
作者：
Li Q;Dai W;Chen X;Su D;Yu W;Gu X
通讯作者：
Gu X
2001-2020 年关于神经血管单元在中风中的作用的 100 篇最常被引用的文章：文献计量分析
影响因子：
5.5
作者：
Xie L;Lu B;Ma Y;Yin J;Zhai X;Chen C;Xie W;Zhang Y;Zheng L;Li P
通讯作者：
Li P
影响因子：
64.8
作者：
Vasan N;Baselga J;Hyman DM
通讯作者：
Hyman DM
影响因子：
64.8
作者：
Li S;Liu M;Do MH;Chou C;Stamatiades EG;Nixon BG;Shi W;Zhang X;Li P;Gao S;Capistrano KJ;Xu H;Cheung NV;Li MO
通讯作者：
Li MO